Who invested in Anthos Therapeutics?
Anthos Therapeutics's investors include Novartis.

Funding summaryUpdated 26 Oct 2026
$250Mraised across 1 round since 2019, from 1 source
Anthos Therapeutics's investors include Novartis.
Anthos Therapeutics has raised $250M across 1 round since 2019.
Anthos Therapeutics's most recent round was a Series A of $250M in Feb 2019.
Its most recent round, $250M in Feb 2019, is also its largest on record.
Anthos Therapeutics's first round on record, in Feb 2019, was backed by Novartis.
Anthos Therapeutics's latest named round is a Series A, in Feb 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.